Monday, June 15, 2026

Celltrion Gets Global IB Upgrades: Morgan Stanley Raises Target to $206.25 as New Biosimilars Lift Margins

Celltrion is expanding through biosimilars and new drug development, attracting global investor interest and raising target stock prices.

How South Korea Plans to De-escalate Tensions After North’s Drone Accusations

South Korea aims to reduce tensions with North Korea amid drone incident, prioritizing investigation and communication over military response.

OpenAI Seeks Greater Autonomy as Partnership With Microsoft Evolves

OpenAI plans to reduce its revenue-sharing ratio with Microsoft, aiming for greater financial independence while maintaining partnership.

Tag: defect

No posts to display

Top News

- Our Sponsors Ad -

Follow us